Skip to main content
Fig. 4 | BMC Surgery

Fig. 4

From: Neoadjuvant chemotherapy weakens the prognostic value of the pathological tumor burden score for colorectal cancer liver metastases

Fig. 4

Comparison of recurrence-free survival (RFS) and overall survival (OS) after curative liver resection for patients who received neoadjuvant therapy stratified by NAC regimen. a, Comparison of RFS in the low and high TBS groups among patients with oxaliplatin-based NAC. b, Comparison of OS in the low and high TBS groups among patients with oxaliplatin-based NAC. c, Comparison of RFS in the low and high TBS groups among patients with irinotecan-based NAC. d, Comparison of OS in the low and high TBS groups among patients with irinotecan-based NAC.

Back to article page

BMC Surgery

ISSN: 1471-2482

Contact us